Evidence for the Association of Unexplained Pulmonary Hypertension in Children With the Major Histocompatibility Complex

BackgroundA link between primary pulmonary hypertension (PPH) and autoimmune disorders has been postulated. To investigate this relation, we performed immunofluorescent antinuclear antibody tests (ANA) and serological human leukocyte antigen (HLA)-A, B, C, DR, and DQ typing on two groups of Caucasian children with unexplained pulmonary hypertension (PHT) and their parents. Methods and ResultsGroup 1 consisted of 17 children with PPH including two patients with familial PPH and three patients with trivial congenital pulmonary to systemic communications. Group 2 consisted of 13 children with advanced PHT and anatomically large congenital pulmonary to systemic communications (PHT+shunt). Both groups had comparably severe pulmonary vascular disease documented by cardiac catheterization. The following statistically significant data (p < 0.05) were obtained when the study groups were compared with those published for normal controls. Although positive ANAs and varying titers of autoantibodies were found in both groups of children and mothers (not fathers), +ANAs were only significant for the maternal groups. The PPH (group 1) children had increased frequencies of HLA-DR3, DRw52, and DQw2 and decreased DR5, whereas the group 2 (PHT+shunt) children (also their parents) had no statistically significant alterations in any of the DR or DQ alleles. The PPH mothers had decreased DQw3, an allele in linkage disequilibrium with DR5 ConclusionsThese immunogenetic data suggest that childhood PPH appears to be associated with the major histocompatibility complex alleles HLA-DR3, DRw52, and DQw2. This newly found correlation of juvenile PPH with these alleles adds this disease to the DR3+ group of autoimmune diseases. Further studies are needed to determine whether there is also an immunological or autoimmune component in some children with PHT+shunt lesions because this group lacked an HLA association.

[1]  S. Yokota.  Mixed connective tissue disease in childhood , 1993, Acta paediatrica Japonica : Overseas edition.

[2]  H. Moses,et al.  Transforming growth factor-beta activity in sheep lung lymph during the development of pulmonary hypertension. , 1990, The Journal of clinical investigation.

[3]  P. Schur,et al.  The effect of ethnicity on major histocompatibility complex complement allotypes and extended haplotypes in patients with systemic lupus erythematosus. , 1990, Arthritis and rheumatism.

[4]  J. D. Capra,et al.  Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. , 1990, The New England journal of medicine.

[5]  P. Marrack,et al.  The role of the T cell receptor in positive and negative selection of developing T cells. , 1990, Science.

[6]  M. Meurer,et al.  Immunogenetic associations of scleroderma-related antinuclear antibodies. , 1990, Arthritis and rheumatism.

[7]  T. Zhao,et al.  HLA-DR, DQ antigens in North American Caucasians. , 1990, Tissue antigens.

[8]  R. Barst,et al.  Isolated pulmonary hypertension in the grandchild of a kindred with scleroderma (systemic sclerosis): "neonatal scleroderma"? , 1989, The Journal of rheumatology.

[9]  J. Volanakis,et al.  Individuals with IgA deficiency and common variable immunodeficiency share polymorphisms of major histocompatibility complex class III genes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[10]  F. Arnett,et al.  Antibodies against Ku protein in sera from patients with autoimmune diseases. , 1989, Clinical and experimental immunology.

[11]  I. Dunham,et al.  Human major histocompatibility complex contains genes for the major heat shock protein HSP70. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[13]  J. H. Brown.  A hypothetical model of the foreign antigen binding site of Class II histocompatibility molecules , 1988, Nature.

[14]  I. Dunham,et al.  Molecular mapping of the human major histocompatibility complex by pulsed-field gel electrophoresis. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[15]  E H Bergofsky,et al.  Primary pulmonary hypertension. A national prospective study. , 1987, Annals of internal medicine.

[16]  R. Warren,et al.  Altered T-cell subsets and defective T-cell function in young children with Down syndrome (trisomy-21). , 1987, Immunological investigations.

[17]  R. Philip,et al.  Abnormalities of the immune response to influenza antigen in Down syndrome (trisomy 21). , 1987, Progress in clinical and biological research.

[18]  G. Reimer,et al.  Autoantibody to RNA polymerase I in scleroderma sera. , 1987, The Journal of clinical investigation.

[19]  B. Brundage,et al.  Antinuclear antibodies in primary pulmonary hypertension. , 1986, Journal of the American College of Cardiology.

[20]  J. Rotter,et al.  Preferential transmission of diabetic alleles within the HLA gene complex. , 1986, The New England journal of medicine.

[21]  B. Mach,et al.  High-resolution analysis of the human HLA-DR polymorphism by hybridization with sequence-specific oligonucleotide probes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[22]  T. Medsger,et al.  Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. , 1986, Arthritis and rheumatism.

[23]  P. Gregersen,et al.  Molecular diversity of HLA-DR4 haplotypes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[24]  G. Hughes,et al.  Rheumatoid arthritis and pulmonary hypertension. A report of three cases. , 1985, The Journal of rheumatology.

[25]  R. Ochs,et al.  Fibrillarin: a new protein of the nucleolus identified by autoimmune sera , 1985, Biology of the cell.

[26]  M. Hochberg,et al.  Sjögren's syndrome. Influence of multiple HLA-D region alloantigens on clinical and serologic expression. , 1984, Arthritis and rheumatism.

[27]  M. Koss,et al.  Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus. , 1984, Seminars in arthritis and rheumatism.

[28]  F. Graziano,et al.  Pulmonary hypertension in a patient with mixed connective tissue disease: clinical and pathologic findings, and review of literature. , 1983, Clinical and experimental rheumatology.

[29]  E. Yunis,et al.  Extended HLA/complement allele haplotypes: evidence for T/t-like complex in man. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[31]  F. Arnett,et al.  The Jo-1 antibody system in myositis: relationships to clinical features and HLA. , 1981, The Journal of rheumatology.

[32]  A. Masi.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.

[33]  B. Dupont,et al.  Two HLA-linked loci controlling the fourth component of human complement. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[34]  B. Dupont,et al.  CLOSE GENETIC LINKAGE BETWEEN HLA AND CONGENITAL ADRENAL HYPERPLASIA (21-HYDROXYLASE DEFICIENCY) , 1977, The Lancet.

[35]  W. Gersony,et al.  Clinical course in ventricular septal defect. , 1977, Circulation.

[36]  M. Torres,et al.  Nomenclature for factors of the HLA system. , 2011, Bulletin of the World Health Organization.

[37]  E. Tan,et al.  Profiles of antinuclear antibodies in systemic rheumatic diseases. , 1975, Annals of internal medicine.

[38]  A. Rawson,et al.  A study of etiologic factors in so-called primary pulmonary hypertension. , 1960, Archives of internal medicine.

[39]  J. Aitchison,et al.  PULMONARY HYPERTENSION IN DERMATOMYOSITIS , 1956, British heart journal.